Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Journal of Proteome Research|January 23, 2009
Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stageYanfei Wang, Rong Wu, Kathleen R Cho, et al.Nature Immunology|October 31, 2017
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumorTomasz Maj, Wei Wang, Joel Crespo, et al.JCI Insight|August 12, 2020
Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasisHoujun Xia, Shasha Li, Xiong Li, et al.Gynecologic Oncology|August 29, 2017
Gynecologic melanomas: A clinicopathologic and molecular analysisAaron M Udager, Nora K Frisch, Linda J Hong, et al.Cell|May 3, 2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian CancerWeimin Wang, Ilona Kryczek, Lubomír Dostál, et al.Gynecologic Oncology|January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258Aine Clements, Danielle Enserro, Kyle C Strickland, et al.JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.Nature|September 4, 2020
Cancer SLC43A2 alters T cell methionine metabolism and histone methylationYingjie Bian, Wei Li, Daniel M Kremer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)Brian M Slomovitz, S John Weroha, Wei Deng, et al.Genomics|June 18, 2005
High-density single-nucleotide polymorphism maps of the human genomeRaymond D Miller, Michael S Phillips, Inho Jo, et al.Pageof 6